Clinical trial
Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously…
NCT01467427 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT01467427 |
|---|---|
| Title | Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B. |
| Official title | Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B |
| Acronym | paradigm™5 |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Congenital Bleeding Disorder, Haemophilia B |
| Intervention type | Drug |
| Interventions | nonacog beta pegol |
| Enrollment | 25 |
| Start date | May 16, 2012 |
| Primary completion | Nov 17, 2023 |
| Completion | Nov 17, 2023 |
| First posted | Nov 8, 2011 |
| Last update posted | Dec 23, 2025 |
| Countries | Brazil, Canada, Croatia, France, Germany, Italy, Japan, Malaysia, Taiwan, Turkey (Türkiye), United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: